RECRO PHARMA INC's ticker is REPH and the CUSIP is 75629F109. A total of 49 filers reported holding RECRO PHARMA INC in Q4 2022. The put-call ratio across all filers is 0.02 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,770,338 | -0.6% | 8,039,100 | +133.0% | 1.48% | -53.4% |
| Q2 2023 | $3,795,000 | -23.2% | 3,450,000 | -16.9% | 3.18% | -29.0% |
| Q1 2023 | $4,938,500 | -18.2% | 4,150,000 | +2.5% | 4.48% | -29.5% |
| Q4 2022 | $6,034,500 | +86.5% | 4,050,000 | +54.6% | 6.36% | +60.9% |
| Q3 2022 | $3,236,000 | +66.1% | 2,620,000 | +6.9% | 3.95% | +66.2% |
| Q2 2022 | $1,948,000 | -69.2% | 2,450,000 | -30.2% | 2.38% | -56.0% |
| Q1 2022 | $6,318,000 | +15.5% | 3,510,000 | +9.7% | 5.40% | +47.3% |
| Q4 2021 | $5,472,000 | -18.4% | 3,200,000 | -1.7% | 3.67% | -25.5% |
| Q3 2021 | $6,705,000 | +33.8% | 3,255,000 | +50.0% | 4.92% | +45.1% |
| Q2 2021 | $5,013,000 | +220.9% | 2,170,000 | +287.5% | 3.39% | +192.8% |
| Q1 2021 | $1,562,000 | – | 560,000 | – | 1.16% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Engine Capital Management, LP | 872,494 | $6,195,000 | 3.64% |
| Newtyn Management, LLC | 1,600,000 | $11,360,000 | 2.22% |
| Broadfin Capital, LLC | 2,048,025 | $14,541,000 | 1.91% |
| Balter Liquid Alternatives, LLC | 92,167 | $654,000 | 0.45% |
| ESSEX INVESTMENT MANAGEMENT CO LLC | 515,414 | $3,660,000 | 0.29% |
| JT Stratford LLC | 45,367 | $322,000 | 0.21% |
| Opus Point Partners Management, LLC | 11,353 | $81,000 | 0.18% |
| Alyeska Investment Group, L.P. | 964,000 | $6,844,000 | 0.10% |
| KENNEDY CAPITAL MANAGEMENT LLC | 500,625 | $3,554,000 | 0.09% |
| Monarch Partners Asset Management LLC | 55,857 | $397,000 | 0.06% |